Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms

Oncogene

Volumn 32, Issue 20, 2013, Pages 2586-2591

  Eissmann M ^a   Melzer, I M ^a   Fernandez S B M ^a,i   Michel, G ^b,j   Hrabe De Angelis M ^b,c   Hoefler, G ^d   Finkenwirth, P ^a   Jauch, A ^e   Schoell, B ^e   Grez, M ^a   Schmidt, M ^f   Bartholomae, C C ^f   Newrzela, S ^g   Haetscher, N ^a   Rieger, M A ^a   Zachskorn, C ^h   Mittelbronn, M ^h   Zornig M ^a  

^a INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^h Institute of Neurology (Edinger Institute)   (Germany)

ⁱ CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

more..

Author keywords

Acute lymphoblastic leukemia; Apoptosis; AVEN; p53; T ALL; Transgenic mice

Indexed keywords

PROTEIN; PROTEIN AVEN; PROTEIN P53; UNCLASSIFIED DRUG;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HETEROZYGOSITY; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T CELL LYMPHOMA; TUMOR GROWTH; TUMOR XENOGRAFT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BASE SEQUENCE; CELL LINE, TUMOR; GENE EXPRESSION REGULATION, LEUKEMIC; GENE KNOCKDOWN TECHNIQUES; GENES, P53; HUMANS; LYMPHOMA, T-CELL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; THYMOCYTES; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 84878014063     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.263     Document Type: Article

References (28)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000; 100: 57-70. (Pubitemid 30046295)
2. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
3. Xu G, Shi Y. Apoptosis signaling pathways and lymphocyte homeostasis. Cell Res 2007; 17: 759-771. (Pubitemid 47411431)
4. Ozoren N, El-Deiry WS. Cell surface Death Receptor signaling in normal and cancer cells. Semin Cancer Biol 2003; 13: 135-147. (Pubitemid 36321814)
5. Vangestel C, Van de Wiele C, Mees G, Peeters M. Forcing cancer cells to commit suicide. Cancer Biother Radiopharm 2009; 24: 395-407.
6. Brenner D, Mak TW. Mitochondrial cell death effectors. Curr Opin Cell Biol 2009; 21: 871-877.
7. Hajra KM, Liu JR. Apoptosome dysfunction in human cancer. Apoptosis 2004; 9: 691-704. (Pubitemid 40941198)
8. Ledgerwood EC, Morison IM. Targeting the apoptosome for cancer therapy. Clin Cancer Res 2009; 15: 420-424.
9. Bao Q, Shi Y. Apoptosome: a platform for the activation of initiator caspases. Cell Death Differ 2007; 14: 56-65. (Pubitemid 44911894)
10. Bratton SB, Salvesen GS. Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci 2010; 123(Part 19): 3209-3214.
11. Chau BN, Cheng EH, Kerr DA, Hardwick JM. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell 2000; 6: 31-40.
12. Esmaili AM, Johnson EL, Thaivalappil SS, Kuhn HM, Kornbluth S, Irusta PM. Regulation of the ATM-activator protein Aven by CRM1-dependent nuclear export. Cell Cycle 2010; 9: 3913-3920.
13. Guo JY, Yamada A, Kajino T, Wu JQ, Tang W, Freel CD et al. Aven-dependent activation of ATM following DNA damage. Curr Biol 2008; 18: 933-942.
14. Paydas S, Tanriverdi K, Yavuz S, Disel U, Sahin B, Burgut R. Survivin and aven: two distinct antiapoptotic signals in acute leukemias. Ann Oncol 2003; 14: 1045-1050. (Pubitemid 36950168)
15. Choi J, Hwang YK, Sung KW, Kim DH, Yoo KH, Jung HL et al. Aven overexpression: association with poor prognosis in childhood acute lymphoblastic leukemia. Leuk Res 2006; 30: 1019-1025. (Pubitemid 43831177)
16. Burkhardt B. Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases? Br J Haematol 2010; 149: 653-668.
17. Cleaver AL, Beesley AH, Firth MJ, Sturges NC, O'Leary RA, Hunger SP et al. Genebased outcome prediction in multiple cohorts of pediatric T-cell acute lymphoblastic leukemia: a Children's Oncology Group study. Mol Cancer 2010; 9: 105.
18. de Leval L, Bisig B, Thielen C, Boniver J, Gaulard P. Molecular classification of T-cell lymphomas. Crit Rev Oncol Hematol 2009; 72: 125-143.
19. Paolini S, Gazzola A, Sabattini E, Bacci F, Pileri S, Piccaluga PP. Pathobiology of acute lymphoblastic leukemia. Semin Diagn Pathol 2011; 28: 124-134.
20. Riz I, Hawley TS, Luu TV, Lee NH, TLX1 Hawley RG. and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells. Mol Cancer 2010; 9: 181.
21. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th edn (WHO Press, Geneva, Switzerland, 2008).
22. Swan KA, Alberola-Ila J, Gross JA, Appleby MW, Forbush KA, Thomas JF et al. Involvement of p21ras distinguishes positive and negative selection in thymocytes. EMBO J 1995; 14: 276-285.
23. Donehower LA. The p53-deficient mouse: a model for basic and applied cancer studies. Semin Cancer Biol 1996; 7: 269-278. (Pubitemid 27182786)
24. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery Jr CA, Butel JS et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356: 215-221.
25. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT et al. Tumor spectrum analysis in p53-mutant mice. Curr Biol 1994; 4: 1-7.
26. Imada K. Immunodeficient mouse models of lymphoid tumors. Int J Hematol 2003; 77: 336-341. (Pubitemid 37121828)
27. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N. Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8;21 chromosome translocation. Blood 1991; 77: 2031-2036.
28. Riccardi C, Nicoletti I. Analysis of apoptosis by propidium iodide staining and flow cytometry. Nat Protoc 2006; 1: 1458-1461.